(Q41572327)

3 October 2017

The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes (English)

1 reference

3 October 2017

7

H J Alter

1 reference

3 October 2017

R Loomba

1

1 reference

3 October 2017

M M Rivera

2

1 reference

3 October 2017

R McBurney

3

1 reference

3 October 2017

Y Park

4

1 reference

3 October 2017

V Haynes-Williams

5

1 reference

3 October 2017

B Rehermann

6

1 reference

3 October 2017

S K Herrine

8

1 reference

3 October 2017

T J Liang

9

1 reference

3 October 2017

J H Hoofnagle

10

1 reference

3 October 2017

T Heller

11

1 reference

3 October 2017

language of work or name

English

0 references

publication date

29 December 2010

1 reference

Alimentary Pharmacology & Therapeutics

3 October 2017

1 reference

3 October 2017

33

1 reference

3 October 2017

5

1 reference

3 October 2017

559-565

1 reference

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

3 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Immunology of hepatitis B virus and hepatitis C virus infection

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Acute hepatitis C: a multifaceted disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

The epidemiology of acute and chronic hepatitis C.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

The burden of hepatitis C in the United States

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Trends in health care resource use for hepatitis C virus infection in the United States

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Treatment of acute hepatitis C with interferon alfa-2b

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5577910

Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response

19 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21198704

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2036.2010.04549.X

1 reference

3 October 2017

1 reference

3 October 2017

PubMed publication ID

21198704

1 reference